Dr. Reddy’s gets CDSCO approval for Zytorvi in advanced esophageal cancer
Toripalimab in combination with cisplatin and paclitaxel is approved for first-line treatment of adult patients with unresectable…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Toripalimab
Toripalimab can fortify Dr. Reddy’s oncology portfolio as first checkpoint inhibitor for NPC in…
Dr. Reddy's Laboratories, in collaboration with Shanghai Junshi Biosciences has recently launched checkpoint inhibitor Zytorvi…
Dr. Reddy’s launches Toripalimab under the brand name Zytorvi in India
Toripalimab is an immuno-oncology drug approved for the treatment of nasopharyngeal carcinoma
Junshi Biosciences gets US FDA Breakthrough Therapy Designation for Toripalimab to treat…
It is the first anti-PD-1 antibody from China to receive BTD